Metropolitan Life Insurance Company (MetLife)’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,662	Closed	-$174K	–	2528
2018 Q1	$174K	Buy	+4,662	New	+$196K	﹤0.01%	1973

Metropolitan Life Insurance Company (MetLife)'s ARMO Position: Q2 2018 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 4,662 shares — an estimated $174K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $174K in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

Metropolitan Life Insurance Company (MetLife) reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 4,662 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $174K.
Metropolitan Life Insurance Company (MetLife) first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
Metropolitan Life Insurance Company (MetLife)'s ARMO BioSciences, Inc. Common Stock position peaked at $174K in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2018, filed 15 Aug 2018.